Simvastatin induces KRAS translocation in KRAS mutant colorectal cancer cells and may influence the susceptibility to anti-EGFR therapy

Author(s):
Krens, L.; Pullen, C.M.C.; Baak-Pablo, R.F.; Guchelaar, H.J. (0000-0002-7085-1383); Straaten, R.J.H.M. van der
Published
2013
Publication type
Article / Letter to editor
Date issued
2013-09-30
Language
English
Is part of
European Journal of Cancer (2013), Vol. 49, p. S495-S495
hdl
1887/101386